Nicox: 2024 Ordinary Shareholder Meeting
June 27, 2024 11:30 ET
|
NICOX SA
Press Release Nicox: 2024 Ordinary Shareholder MeetingJune 27, 2024 – release at 17:30 CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, ALCOX), an international ophthalmology...
Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors
June 27, 2024 08:49 ET
|
Spherix Global Insights
Exton, Pennsylvania, June 27, 2024 (GLOBE NEWSWIRE) -- Prior to 2023, there was no treatment for GA, a progressive form of dry age-related macular degeneration that results in blindness. That...
Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery
June 27, 2024 07:05 ET
|
Clearside Biomedical, Inc.
- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery - - Target Profile for CLS-AX in...
Oculis and EURETINA Announces the Ramin Tadayoni Award
June 27, 2024 06:30 ET
|
Oculis Holding AG
ZUG, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and...
EyePoint Pharmaceuticals to Highlight DURAVYU™ (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024
June 26, 2024 08:00 ET
|
EyePoint Pharmaceuticals, Inc.
– Phase 3 trial design for the LUGANO and LUCIA pivotal non-inferiority trials of DURAVYU in wet AMD based on positive EOP2 meeting with FDA; on track for trial initiation in 2H 2024 –– Positive...
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Continued Unmet Needs and Track New Launches
June 26, 2024 04:00 ET
|
Spherix Global Insights
EXTON, PA, June 26, 2024 (GLOBE NEWSWIRE) -- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disorder in which red blood cells prematurely break apart, a process known as hemolysis....
Global Biomaterials Market Size To Exceed USD 528.5 Billion By 2033 | CAGR of 13.77%
June 25, 2024 20:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 25, 2024 (GLOBE NEWSWIRE) -- The Global Biomaterials Market Size is to Grow from USD 145.5 Billion in 2023 to USD 528.5 Billion by 2033, at a Compound Annual Growth...
Global Bioinformatics Services Market Size To Worth USD 12.71 Billion By 2033 | CAGR Of 14.40%
June 25, 2024 14:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 25, 2024 (GLOBE NEWSWIRE) -- The Global Bioinformatics Services Market Size is to Grow from USD 3.31 Billion in 2023 to USD 12.71 Billion by 2033, at a Compound Annual...
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
June 25, 2024 09:00 ET
|
Samsung Bioepis
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
June 25, 2024 06:26 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, June 25, 2024 (GLOBE NEWSWIRE) -- On June 25, China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) announced the completion of...